These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25875328)

  • 1. Novel carboxypeptidase A6 (CPA6) mutations identified in patients with juvenile myoclonic and generalized epilepsy.
    Sapio MR; Vessaz M; Thomas P; Genton P; Fricker LD; Salzmann A
    PLoS One; 2015; 10(4):e0123180. PubMed ID: 25875328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring carboxypeptidase A6 mutations: effect on enzyme function and association with epilepsy.
    Sapio MR; Salzmann A; Vessaz M; Crespel A; Lyons PJ; Malafosse A; Fricker LD
    J Biol Chem; 2012 Dec; 287(51):42900-9. PubMed ID: 23105115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxypeptidase A6 gene (CPA6) mutations in a recessive familial form of febrile seizures and temporal lobe epilepsy and in sporadic temporal lobe epilepsy.
    Salzmann A; Guipponi M; Lyons PJ; Fricker LD; Sapio M; Lambercy C; Buresi C; Ouled Amar Bencheikh B; Lahjouji F; Ouazzani R; Crespel A; Chaigne D; Malafosse A
    Hum Mutat; 2012 Jan; 33(1):124-35. PubMed ID: 21922598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling Molecules.
    Lopes MW; Sapio MR; Leal RB; Fricker LD
    PLoS One; 2016; 11(4):e0152905. PubMed ID: 27050163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboxypeptidase A6 in zebrafish development and implications for VIth cranial nerve pathfinding.
    Lyons PJ; Ma LH; Baker R; Fricker LD
    PLoS One; 2010 Sep; 5(9):e12967. PubMed ID: 20885977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate specificity of human carboxypeptidase A6.
    Lyons PJ; Fricker LD
    J Biol Chem; 2010 Dec; 285(49):38234-42. PubMed ID: 20855895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of carboxypeptidase A6, an extracellular matrix peptidase.
    Lyons PJ; Callaway MB; Fricker LD
    J Biol Chem; 2008 Mar; 283(11):7054-63. PubMed ID: 18178555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy.
    Cossette P; Liu L; Brisebois K; Dong H; Lortie A; Vanasse M; Saint-Hilaire JM; Carmant L; Verner A; Lu WY; Wang YT; Rouleau GA
    Nat Genet; 2002 Jun; 31(2):184-9. PubMed ID: 11992121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome in adolescent-onset generalized genetic epilepsies.
    Vorderwülbecke BJ; Kowski AB; Kirschbaum A; Merkle H; Senf P; Janz D; Holtkamp M
    Epilepsia; 2017 Jul; 58(7):1244-1250. PubMed ID: 28464258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms.
    Wallace RH; Hodgson BL; Grinton BE; Gardiner RM; Robinson R; Rodriguez-Casero V; Sadleir L; Morgan J; Harkin LA; Dibbens LM; Yamamoto T; Andermann E; Mulley JC; Berkovic SF; Scheffer IE
    Neurology; 2003 Sep; 61(6):765-9. PubMed ID: 14504318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel SCN1A mutation associated with generalized epilepsy with febrile seizures plus--and prevalence of variants in patients with epilepsy.
    Escayg A; Heils A; MacDonald BT; Haug K; Sander T; Meisler MH
    Am J Hum Genet; 2001 Apr; 68(4):866-73. PubMed ID: 11254445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CPA6 promoter methylation in focal epilepsy and in febrile seizures.
    Belhedi N; Perroud N; Karege F; Vessaz M; Malafosse A; Salzmann A
    Epilepsy Res; 2014 Jan; 108(1):144-8. PubMed ID: 24290490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxypeptidase A6 was identified and validated as a novel potential biomarker for predicting the occurrence of active ulcerative colitis.
    Wang H; Zhang M; Zhang M; Wang F; Liu J; Zhao Q
    J Cell Mol Med; 2020 Aug; 24(15):8803-8813. PubMed ID: 32570281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotype-phenotype correlations in a group of 15 SCN1A-mutated Italian patients with GEFS+ spectrum (seizures plus, classical and borderline severe myoclonic epilepsy of infancy).
    Nicita F; Spalice A; Papetti L; Ursitti F; Parisi P; Gennaro E; Zara F; Iannetti P
    J Child Neurol; 2010 Nov; 25(11):1369-76. PubMed ID: 20729507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors of higher drug load for seizure freedom in idiopathic generalized epilepsy: Comparison between juvenile myoclonic epilepsy and other types.
    Kitazawa Y; Jin K; Kakisaka Y; Fujikawa M; Tanaka F; Nakasato N
    Epilepsy Res; 2018 Aug; 144():20-24. PubMed ID: 29729533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complex therapy of idiopathic forms of epilepsy with small doses of valproates and levetiracetam].
    Karlov VA; Freĭdkova NV; Rusanova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6 Pt 2):37-9. PubMed ID: 22983238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia.
    Escayg A; De Waard M; Lee DD; Bichet D; Wolf P; Mayer T; Johnston J; Baloh R; Sander T; Meisler MH
    Am J Hum Genet; 2000 May; 66(5):1531-9. PubMed ID: 10762541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
    Gelisse P; Genton P; Kuate C; Pesenti A; Baldy-Moulinier M; Crespel A
    Epilepsia; 2004 Oct; 45(10):1282-6. PubMed ID: 15461683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlations of mutations in the SCN1A gene: from febrile seizures to severe myoclonic epilepsy in infancy.
    Ceulemans BP; Claes LR; Lagae LG
    Pediatr Neurol; 2004 Apr; 30(4):236-43. PubMed ID: 15087100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent treatment resistance in genetic generalized epilepsy: A long-term outcome study in a tertiary epilepsy center.
    Cerulli Irelli E; Morano A; Barone FA; Fisco G; Fanella M; Orlando B; Fattouch J; Manfredi M; Giallonardo AT; Di Bonaventura C
    Epilepsia; 2020 Nov; 61(11):2452-2460. PubMed ID: 33345323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.